Thorough QT/QTc Evaluation of the Cardiac Safety of Enarodustat (JTZ‐951), an Oral Erythropoiesis‐Stimulating Agent, in Healthy Adults-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thorough QT/QTc Evaluation of the Cardiac Safety of Enarodustat (JTZ‐951), an Oral Erythropoiesis‐Stimulating Agent, in Healthy Adults

Published:2021-06-23 Issue:8 Volume:10 Page:884-898
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:Clinical Pharmacology in Drug Development

Author:

Pai Sudhakar M.¹,Yamada Hiroyuki²,Kleiman Robert B.³,Zhuo Rui⁴,Huang Qingtao (Mike)¹,Koretomo Ryosuke⁵

Affiliation:

1. Clinical Pharmacology Akros Pharma, Inc. Princeton New Jersey USA

2. Clinical Pharmacology Japan Tobacco Inc. Pharmaceutical Division Tokyo Japan

3. ERT 1818 Market Street, 10th floor Philadelphia Pennsylvania USA

4. Biostatistics Akros Pharma, Inc. Princeton New Jersey USA

5. Clinical Development Japan Tobacco Inc. Pharmaceutical Division Tokyo Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.933

Reference17 articles.

1. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease

2. Pathogenesis of Renal Anemia

3. What do new ESAs do?;Suzuki S;Kidney and Dialysis,2009

4. Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation

5. Hypoxia and the HIF system in kidney disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The drug-specific properties of hypoxia-inducible factor-prolyl hydroxylase inhibitors in mice reveal a significant contribution of the kidney compared to the liver to erythropoietin induction;Life Sciences;2024-06

2. Effect of the Phosphate Binder Sevelamer Carbonate on the Bioavailability of Enarodustat, an Oral Erythropoiesis Stimulating Agent;Clinical Pharmacology in Drug Development;2023-11-17

3. Treatment of anemia associated with chronic kidney disease with the HIF prolyl hydroxylase inhibitor enarodustat: A review of the evidence;Therapeutic Apheresis and Dialysis;2022-03-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3